Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness, safety and tolerability of the drug
combination: gemcitabine, carboplatin and bevacizumab in patients that have been diagnosed
with platinum sensitive recurrent ovarian cancer, fallopian tube or primary peritoneal
cancer.